This study will evaluate an investigational drug to treat seasonal ragweed allergy. Participants will receive the study medication and study-related care at no cost, and compensation of up to $660 is available.
This study will evaluate an investigational drug for Alzheimer's disease. Symptoms include forgetfulness, loss of short term memory, repeating questions or phrases, and increased difficulty in handling daily activities.